{"id":52989,"date":"2023-09-20T09:41:06","date_gmt":"2023-09-20T09:41:06","guid":{"rendered":"https:\/\/medsname.com\/mesacol\/"},"modified":"2026-05-01T10:49:12","modified_gmt":"2026-05-01T10:49:12","slug":"mesacol","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/mesacol\/","title":{"rendered":"Mesacol"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Mesacol?<\/h3>\n<p style=\"margin:0;\"><strong>Mesacol<\/strong> \u03c0\u03b5\u03c1\u03b9\u03ad\u03c7\u03b5\u03b9 <strong>mesalamine<\/strong> (also called mesalazine or 5-aminosalicylic acid, 5-ASA) &mdash; a <strong>topical intestinal anti-inflammatory drug<\/strong> \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03b5\u03af\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 <strong>treat ulcerative colitis (UC) and maintain remission<\/strong>. It acts <em>locally<\/em> in the colon lining, suppressing the inflammatory pathways that drive UC flares. <strong>\u03a3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc:<\/strong> mesalamine is <strong>not a treatment for irritable bowel syndrome (IBS)<\/strong>. UC is a chronic inflammatory disease (IBD); IBS is a functional disorder with no bowel inflammation &mdash; different conditions, different drugs. For UC, mesalamine is first-line therapy in mild-to-moderate disease. Typical dose: 400 mg or 800 mg; see dosing section. Once daily (OD\/MMX) or divided doses depending on formulation. Side effects are usually mild &mdash; headache, nausea, abdominal discomfort; rare renal effects warrant periodic kidney-function checks.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>\u0391\u03c5\u03c4\u03cc \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03c4\u03b5 \u03bc\u03b5 \u03c4\u03b7\u03bd MedsBase:<\/strong> \u03a0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae\u03c2 WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 <a href=\"https:\/\/medsbase.com\/el\/reviews\/\">\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>\u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n<h2 class=\"wp-block-heading\">What Is Mesacol?<\/h2>\n<p>Mesacol is an oral <strong>aminosalicylate (5-ASA)<\/strong> medicine containing <strong>mesalamine<\/strong> (400 mg or 800 mg), supplied as delayed-release Eudragit-S enteric-coated tablets. Manufactured by Sun Pharma in packs of 30, 60, 90 or 180 tablets. Mesalamine is the active metabolite of older sulfasalazine &mdash; without the sulfapyridine moiety that caused most of sulfasalazine&rsquo;s systemic side effects.<\/p>\n<p>Mesalamine has been a <strong>first-line therapy for mild-to-moderate ulcerative colitis<\/strong> since the 1980s and is recommended as induction and maintenance therapy by ACG, ECCO, and BSG guidelines. The original mesalamine brand Asacol was approved in 1987; today there are several delivery systems (Eudragit-coated, ethylcellulose microgranule, MMX multi-matrix) each designed to release mesalamine at a different point in the gastrointestinal tract.<\/p>\n<h2 class=\"wp-block-heading\">What Is Mesacol Used For?<\/h2>\n<ul>\n<li><strong>Induction of remission<\/strong> in active mild-to-moderate ulcerative colitis<\/li>\n<li><strong>Maintenance of remission<\/strong> in ulcerative colitis<\/li>\n<li><strong>Some mild Crohn&rsquo;s colitis cases<\/strong> (off-label in many countries; evidence is weaker than for UC)<\/li>\n<li><strong>Ulcerative proctitis and left-sided colitis<\/strong> (often combined with rectal mesalamine formulations)<\/li>\n<\/ul>\n<p>Mesacol is <strong>\u03b4\u03b5\u03bd<\/strong> a treatment for:<\/p>\n<ul>\n<li><strong>Irritable bowel syndrome (IBS)<\/strong> &mdash; a functional disorder without mucosal inflammation. IBS is treated with antispasmodics (mebeverine), gut-selective antibiotics for IBS-D (rifaximin), dietary intervention (low-FODMAP), and central modulators (low-dose TCAs\/SSRIs)<\/li>\n<li>Infectious colitis (e.g. <em>C. difficile<\/em>, <em>Salmonella<\/em>, <em>Shigella<\/em>)<\/li>\n<li>Microscopic colitis &mdash; budesonide is preferred<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">How Does Mesacol Work?<\/h2>\n<p>Mesalamine is a topical intestinal anti-inflammatory. Its exact mechanism is multifactorial, involving several anti-inflammatory pathways in the colonic mucosa:<\/p>\n<ul>\n<li><strong>Inhibition of cyclooxygenase and lipoxygenase<\/strong> pathways &mdash; reduces local prostaglandin and leukotriene synthesis<\/li>\n<li><strong>Scavenging of reactive oxygen species<\/strong> produced by neutrophils in inflamed mucosa<\/li>\n<li><strong>Inhibition of NF-&kappa;B<\/strong> &mdash; dampens the transcription of pro-inflammatory cytokines<\/li>\n<li><strong>PPAR-&gamma; agonism<\/strong> in colonocytes &mdash; contributes to resolution of inflammation<\/li>\n<li><strong>Reduces neutrophil chemotaxis<\/strong> into the colonic mucosa<\/li>\n<\/ul>\n<p>Because mesalamine&rsquo;s target is the colonic mucosa, delivery is critical. The delayed-release Eudragit-S enteric-coated tablets of Mesacol is designed to release active drug in the colon rather than being absorbed prematurely in the small intestine. Eudragit-S coating dissolves at pH &ge; 7 (terminal ileum\/colon); Eudragit-L at pH &ge; 6 (duodenum\/jejunum); ethylcellulose microgranules release continuously; MMX uses a lipophilic\/hydrophilic matrix for controlled colonic release.<\/p>\n<h2 class=\"wp-block-heading\">\u0394\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03ba\u03b1\u03b9 \u03a7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7<\/h2>\n<p><strong>Induction of remission in mild-to-moderate UC:<\/strong> 2.4&ndash;4.8&nbsp;g\/day in divided doses. <strong>Maintenance of remission:<\/strong> 1.6&ndash;2.4&nbsp;g\/day.<\/p>\n<ul>\n<li>Take with or shortly after food (reduces GI upset and may improve colonic delivery).<\/li>\n<li><strong>Swallow tablets whole<\/strong> &mdash; do not crush or chew Eudragit-coated or MMX tablets; the coating is the delivery system.<\/li>\n<li>Seeing intact tablet shells in stool can happen with some formulations (particularly MMX &ldquo;ghost&rdquo; tablets) &mdash; this is expected and does not mean the drug failed to absorb.<\/li>\n<li>Maintain good hydration &mdash; supports renal clearance.<\/li>\n<li><strong>Adherence is critical.<\/strong> Mesalamine is a daily maintenance drug; missing doses is the single biggest predictor of UC relapse.<\/li>\n<li>Miss a dose &mdash; take it as soon as you remember, unless close to the next dose; do not double up.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n<p>Mesalamine is usually well-tolerated compared with sulfasalazine and immunomodulators.<\/p>\n<p><strong>\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2:<\/strong><\/p>\n<ul>\n<li>\u039a\u03b5\u03c6\u03b1\u03bb\u03b1\u03bb\u03b3\u03af\u03b1<\/li>\n<li>Nausea, abdominal pain, flatulence<\/li>\n<li>Diarrhoea (ironic for a colitis drug, but real &mdash; 1&ndash;3% of users)<\/li>\n<li>Rash, itching<\/li>\n<li>Occasional hair loss (mild, reversible)<\/li>\n<\/ul>\n<p><strong>\u03a3\u03c0\u03ac\u03bd\u03b9\u03b1 \u03b1\u03bb\u03bb\u03ac \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ac:<\/strong><\/p>\n<ul>\n<li><strong>\u039d\u03b5\u03c6\u03c1\u03b9\u03ba\u03ae \u03b4\u03c5\u03c3\u03bb\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03af\u03b1<\/strong> &mdash; interstitial nephritis is a rare but documented class effect. Check serum creatinine at baseline, at 3 months, then annually. Discontinue if eGFR drops by &gt; 25%.<\/li>\n<li><strong>Acute mesalamine intolerance syndrome<\/strong> &mdash; paradoxical worsening of colitis symptoms shortly after starting. Very rare; stop the drug.<\/li>\n<li><strong>Blood dyscrasias<\/strong> &mdash; rare neutropenia, thrombocytopenia; check FBC if unexplained infection or bruising.<\/li>\n<li><strong>Pancreatitis<\/strong> \u2014 \u03c0\u03bf\u03bb\u03cd \u03c3\u03c0\u03ac\u03bd\u03b9\u03b1<\/li>\n<li><strong>Myocarditis \/ pericarditis<\/strong> &mdash; very rare; new chest pain warrants evaluation<\/li>\n<li><strong>\u0397\u03c0\u03b1\u03c4\u03af\u03c4\u03b9\u03b4\u03b1<\/strong> &mdash; very rare, usually reversible<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n<ul>\n<li><strong>Azathioprine \/ mercaptopurine \/ thiopurines<\/strong> &mdash; mesalamine inhibits TPMT and can raise thiopurine levels; monitor FBC more closely when the combination is used.<\/li>\n<li><strong>\u039c\u03b7 \u03c3\u03c4\u03b5\u03c1\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03bd\u03c4\u03b9\u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03ce\u03b4\u03b7 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1 (NSAIDs)<\/strong> &mdash; additive renal risk; avoid chronic use.<\/li>\n<li><strong>PPIs and antacids<\/strong> &mdash; may alter gastric pH and disrupt pH-dependent coating dissolution; separate Eudragit-coated mesalamine from high-dose PPIs by 4 hours if possible, or choose a pH-independent formulation.<\/li>\n<li><strong>\u0392\u03b1\u03c1\u03c6\u03b1\u03c1\u03af\u03bd\u03b7<\/strong> &mdash; possible increased anticoagulant effect; monitor INR when starting.<\/li>\n<li><strong>\u039c\u03b5\u03b8\u03bf\u03c4\u03c1\u03b5\u03be\u03ac\u03c4\u03b7\u03c2<\/strong> &mdash; additive myelosuppression risk.<\/li>\n<li><strong>Live vaccines<\/strong> &mdash; no meaningful interaction with mesalamine alone (unlike with sulfasalazine or biologics).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Who Should Not Take Mesacol?<\/h2>\n<ul>\n<li>Known hypersensitivity to salicylates (including aspirin) or mesalamine<\/li>\n<li>Severe renal impairment (eGFR &lt; 30&nbsp;mL\/min)<\/li>\n<li>\u03a3\u03bf\u03b2\u03b1\u03c1\u03ae \u03b7\u03c0\u03b1\u03c4\u03b9\u03ba\u03ae \u03b4\u03c5\u03c3\u03bb\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03af\u03b1<\/li>\n<li>Children below the label age cutoff (differs by formulation)<\/li>\n<li>Active peptic ulcer disease<\/li>\n<li>Pregnancy and breastfeeding &mdash; mesalamine has a reassuring safety record and is commonly continued through pregnancy when UC control requires it; discuss with your gastroenterologist and obstetrician<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n<p>Store Mesacol below 25&deg;C in a dry place, in the original blister. Keep out of reach of children. Protect from light and moisture.<\/p>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3 class=\"wp-block-heading\">Is mesalamine the same as mesalazine or 5-ASA?<\/h3>\n<p>Yes &mdash; all three names refer to the same molecule (5-aminosalicylic acid). Mesalamine is the US adopted name (USAN); mesalazine is the international non-proprietary name (INN); 5-ASA is the chemical abbreviation. Different brands and regions label it differently.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Mesacol for IBS or general bloating?<\/h3>\n<p>No &mdash; mesalamine does not treat IBS. IBS is a functional disorder; there is no mucosal inflammation for mesalamine to work on. For IBS, first-line treatments are dietary changes (low-FODMAP diet, fibre modification), antispasmodics like mebeverine (Colospa) or hyoscine, and &mdash; for IBS-D specifically &mdash; short courses of rifaximin (Rifagut). Central modulators (low-dose amitriptyline) are used for refractory IBS pain.<\/p>\n<h3 class=\"wp-block-heading\">How long until Mesacol works?<\/h3>\n<p>Symptom improvement typically begins within 1&ndash;2 weeks; full remission in 4&ndash;8 weeks at induction doses. Stool frequency and urgency usually improve first, followed by abdominal pain and finally mucosal healing (visible on colonoscopy at 8&ndash;12 weeks).<\/p>\n<h3 class=\"wp-block-heading\">Do I need to take Mesacol forever?<\/h3>\n<p>Most patients with ulcerative colitis need long-term maintenance mesalamine to stay in remission &mdash; typically at least 1.6&ndash;2.4&nbsp;g\/day. Stopping after remission is achieved leads to relapse within 6&ndash;12 months in most studies. Mesalamine is safe for decades of use when renal function is monitored.<\/p>\n<h3 class=\"wp-block-heading\">Why am I seeing intact tablet shells in my stool?<\/h3>\n<p>Several mesalamine formulations (particularly MMX &ldquo;ghost&rdquo; tablets) pass through largely intact in the stool. This is <em>\u03b1\u03bd\u03b1\u03bc\u03b5\u03bd\u03cc\u03bc\u03b5\u03bd\u03b7<\/em> and the drug has been released inside the colon as designed. If you see the tablet unchanged with no coating damage, check your technique; otherwise no action is needed.<\/p>\n<h3 class=\"wp-block-heading\">Can I take aspirin or NSAIDs with Mesacol?<\/h3>\n<p>Short paracetamol (acetaminophen) is preferred for pain in UC. Chronic NSAID use can both precipitate UC flares <em>\u03ba\u03b1\u03b9<\/em> increase the renal risk of mesalamine &mdash; avoid where possible. Occasional use is usually tolerated.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Mesacol online?<\/h3>\n<p>You can order Mesacol (400 mg or 800 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Related IBS &amp; IBD Medications<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/mesacol\/\">Mesacol &mdash; Mesalamine 400\/800 mg (Sun Pharma)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/asacol\/\">Asacol &mdash; Mesalamine 400 mg (Win-Medicare)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/mesacol-od\/\">Mesacol OD &mdash; Mesalamine 1.2 g once-daily (MMX)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/sazo\/\">Sazo &mdash; Sulfasalazine 500 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/salazar\/\">Salazar &mdash; Sulfasalazine<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/colospa\/\">Colospa &mdash; Mebeverine 135 mg (IBS antispasmodic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/rifagut\/\">Rifagut &mdash; Rifaximin (gut-selective antibiotic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/irritable-bowel-syndrome-ibs-treatment\/\"><strong>Browse all IBS &amp; IBD Medications<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0391\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u0395\u03c5\u03b8\u03cd\u03bd\u03b7\u03c2.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Ulcerative colitis requires specialist (gastroenterology) diagnosis and follow-up, including periodic renal-function checks and surveillance colonoscopy. Worsening symptoms, rectal bleeding, fever, or weight loss warrant urgent review.<\/div>\n<h3 class=\"wp-block-heading\">\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>Mesacol is supplied from a <strong>\u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03b7 WHO-GMP \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae<\/strong>. Every order ships discreetly worldwide and is covered by our <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\">\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a> &mdash; if it does not arrive within 20 business days, we reship at no cost. Mesalamine 400 mg delayed-release is the WHO-recommended first-line for ulcerative colitis induction and maintenance &mdash; topical action with minimal systemic exposure.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Other Gastro Health Medications<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/budez-cr\/\">Budez CR &mdash; Budesonide CR (terminal-ileal Crohn&#8217;s)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/saaz\/\">Saaz &mdash; Sulfasalazine 500 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/pentasa-suppositories\/\">Pentasa Suppositories &mdash; Mesalazine 1 g<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/rifagut\/\">Rifagut &mdash; Rifaximin (gut-selective antibiotic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/colospa\/\">Colospa &mdash; Mebeverine (IBS antispasmodic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/gastro-health\/\"><strong>Browse all Gastro Health Medications<\/strong><\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Treats Inflammatory Bowel Disease<br \/>\n\u2705 Reduces Intestinal Inflammation<br \/>\n\u2705 Relieves Abdominal Pain<br \/>\n\u2705 Improves Digestive Health<\/h5>\n<p><span style=\"color: #999999;\">Mesacol contains Mesalamine<\/span><\/p>","protected":false},"featured_media":52990,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3542,3342,3565],"product_tag":[3566],"class_list":{"0":"post-52989","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-gastro-health","9":"product_cat-general-health","10":"product_cat-irritable-bowel-syndrome-ibs-treatment","11":"product_tag-mesalamine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/52989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=52989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/52990"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=52989"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=52989"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=52989"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=52989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}